Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Predictors, Risk Factors and Outcomes of Patients with SAA with Anti-HLA Class I Antibodies Treated with Immunosuppressive Therapy

Jibran Durrani, Leonard Chen, Ruba Shalhoub, Nu Ri Cha, Xiaoyang Ma, Jennifer Lotter, Olga Rios, Colin O. Wu, Willy A. Flegel, Neal S. Young, Bhavisha A. Patel, Emma M. Groarke

Blood (2022) 140 (Supplement 1): 77–78.

https://doi.org/10.1182/blood-2022-163442

Published: 2022

Journal Articles

HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia

Yoshitaka Zaimoku, Bhavisha A. Patel, Sharon D. Adams, Ruba Shalhoub, Emma M. Groarke, Audrey Ai Chin Lee, Sachiko Kajigaya, Xingmin Feng, Olga Julia Rios, Holly Eager, Lemlem Alemu, Diego Quinones Raffo, Colin O. Wu, Willy A. Flegel, Neal S. Young

Blood (2021) 138 (26): 2799–2809.

https://doi.org/10.1182/blood.2021012895

Published: 2021

Includes: Supplemental data

Journal Articles

COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination

Willy A. Flegel, Kshitij Srivastava, Valeria De Giorgi, Michael R Holbrook, Nicolai V Bovin, Stephen M Henry, Kamille West

Blood (2021) 138 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2021-150795

Published: 2021

Journal Articles

Immune Hemolysis after a Hematopoietic Progenitor Cell Transplantation for Sickle Cell Disease: A Case Report

Rim Abdallah, MD, Marina U Bueno, SBB, Matthew Hsieh, MD, Willy A. Flegel, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-142230

Published: 2020

Journal Articles

Rapid Engraftment, Immune Recovery, and Resolution of Transfusion Dependence in Treatment-Refractory Severe Aplastic Anemia Following Transplantation with Ex Vivo Expanded Umbilical Cord Blood (Omidubicel)

Mohamed Samour, MD, Georg Aue, MD PhD, Joseph Clara, Jennifer Wilder, Robert Reger, MS, Rosa Nadal Rios, MD, Kate Stringaris, MD PhD, Brian Wells, Lisa Cook, Kristen Gunn, Reem A Shalabi, PharmD, Josef Rivero, Patricia Prince, David F. Stroncek, MD, Willy A. Flegel, MD, Xin Tian, PhD, Richard W. Childs, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137771

Published: 2020

Journal Articles

Spectrum and Clinical Significance of HLA Class I Alleles and Their Somatic Mutations in Immune Aplastic Anemia

Yoshitaka Zaimoku, MD PhD, Sharon D. Adams, MT, CHS (ABHI), Bhavisha A Patel, MD, Audrey Ai Chin Lee, MS, CHT (ABHI), Sachiko Kajigaya, PhD, Xingmin Feng, PhD, Olga Rios, RN, Holly DiFebo, RN, Lemlem Alemu, BS, Diego Quinones Raffo, MSc, Emma M. Groarke, MD, Willy A. Flegel, MD, Neal S. Young, MD

Blood (2019) 134 (Supplement_1): 3738.

https://doi.org/10.1182/blood-2019-127359

Published: 2019

Journal Articles

Rapid Engraftment and Immune Recovery in Treatment Refractory Severe Aplastic Anemia Patients Undergoing Ex Vivo Nicotinamide-Expanded (NAM-Expanded) Unrelated Cord Blood Transplantation

Richard W. Childs, MD, Phuong T. Vo, MD, Georg Aue, Jennifer Wilder, Brian Wells, Joseph Clara, MD, Reem Shalabi, Patricia Prince, David F. Stroncek, Robert Reger, MS, Willy A. Flegel, MD, Sharon Adams, MT, CHS (ABHI), Kristen Gunn, Tatyana Worthy, Lisa Cook, Xin Tian

Blood (2018) 132 (Supplement 1): 5789.

https://doi.org/10.1182/blood-2018-99-119546

Published: 2018

Journal Articles

Continuous Platelet Transfusion As a Potential Desensitization Regimen in HLA Class I Alloimmune-Mediated Platelet Refractoriness

Jamal Carter, MD, James Szymanski, MD, Cathy Cantilena, MD, Sharon Adams, MT, CHS (ABHI), Shelley Sahu, MD, Willy A. Flegel, MD

Blood (2017) 130 (Supplement 1): 4925.

https://doi.org/10.1182/blood.V130.Suppl_1.4925.4925

Published: 2017

Journal Articles

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

Elizabeth S. Allen, MD, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD, Harvey G. Klein, MD, John F. Tisdale, MD, Willy A. Flegel

Blood (2016) 128 (22): 3404.

https://doi.org/10.1182/blood.V128.22.3404.3404

Published: 2016

Journal Articles

Complement Inhibition Using Eculizumab Overcomes Platelet Transfusion Refractoriness in Allo-Immunized Patients Receiving HLA Mismatched Platelets

Phuong T. Vo, MD, Enkhtsetseg Purev, Kamille A West, MD, Michael Hochman, Emily C. McDuffee, PhD DO, Tatyana Worthy, Lisa Cook, Catalina Ramos, Brian Wells, Willy A. Flegel, Sharon Adams, Robert N. Reger, Georg Aue, Richard W. Childs

Blood (2016) 128 (22): 3840.

https://doi.org/10.1182/blood.V128.22.3840.3840

Published: 2016

Journal Articles

Excellent Engraftment and Long-Term Survival in Patients with Severe Aplastic Anemia (SAA) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Haplo-Identical CD34+ Cells Combined with a Single Umbilical Cord Blood Unit

Enkhtsetseg Purev, Georg Aue, Ritesh Kotecha, Jennifer Wilder, Hahn M. Khuu, David F. Stroncek, MD, Roger Kurlander, Robert N. Reger, B.S., Willy A. Flegel, Sharon Adams, Lisa Cook, Catalina Ramos, Elena Cho, Richard W. Childs, MD

Blood (2015) 126 (23): 5516.

https://doi.org/10.1182/blood.V126.23.5516.5516

Published: 2015

Journal Articles

Minor Histocompatibility Antigen Mismatch and Incidence of Graft Versus Host Disease, Event-Free, and Overall Survival in Patients Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Brian C Shaffer, MD, Christine Tremblay, BS, Daniel Peaceman, BS, Jennifer Hsu, RN, BSN, Seth M. Steinberg, PhD, Marcela Uribe, CHS, Sharon Adams, CHS, Willy A. Flegel, MD, Steven Z. Pavletic, MD

Blood (2012) 120 (21): 4201.

https://doi.org/10.1182/blood.V120.21.4201.4201

Published: 2012

Journal Articles

Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation

Blood (2011) 118 (21): 654.

https://doi.org/10.1182/blood.V118.21.654.654

Published: 2011

Journal Articles

SNP Genotyping and LD Testing in ERMAP : Revealing Scianna Blood Group Diversity in NIH Blood Donors

Courtney A. Follit, Patricia A. R. Brunker, MD, DPhil, Willy A. Flegel, MD

Blood (2011) 118 (21): 2322.

https://doi.org/10.1182/blood.V118.21.2322.2322

Published: 2011

Journal Articles

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

Stefan Schwartz, Maria Vergoulidou, Eckart Schreier, Christoph Loddenkemper, Mark Reinwald, Martin Schmidt-Hieber, Willy A. Flegel, Eckhard Thiel, Thomas Schneider

Blood (2011) 117 (22): 5850–5856.

https://doi.org/10.1182/blood-2010-12-325886

Published: 2011

Journal Articles

HLA Alloantibody Persistence and De Novo Production of HLA Alloantibodies of Donor Origin Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Ross M Fasano, MD, Sharon Adams, Aleah Smith, Theresa Donohue, MS, PA-C, Charles D. Bolan, Jr., MD, Kyoko Sugimoto, MD, PhD, Willy A. Flegel, MD, Richard Childs, MD

Blood (2010) 116 (21): 1109.

https://doi.org/10.1182/blood.V116.21.1109.1109

Published: 2010

Journal Articles

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management

Ross M. Fasano, Alessandro Monaco, Emily Riehm Meier, Philippe Pary, A. Hallie Lee-Stroka, John Otridge, Harvey G. Klein, Francesco M. Marincola, Naynesh R. Kamani, Naomi L. C. Luban, David Stroncek, Willy A. Flegel

Blood (2010) 116 (15): 2836–2838.

https://doi.org/10.1182/blood-2010-04-279372

Published: 2010

Includes: Supplemental data

Journal Articles

Direct Antiglobulin Test, Ferritin and GPI-Negative Cell Populations in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) during Eculizumab Therapy: Extravascular Hemolysis Unmasked by Efficient Eculizumab-Mediated Inhibition of Intravascular Hemolysis.

Bri tta Höchsmann, Markus Rojewski, Willy A Flegel, Hubert Schrezenmeier

Blood (2008) 112 (11): 3440.

https://doi.org/10.1182/blood.V112.11.3440.3440

Published: 2008

Journal Articles

Successful Allogeneic HSCT in a Patient with Chronic Granulomatous Disease and McLeod Phenotype after Sensitization to Kx- and K- Antigens.

Manfred Hoenig, Ansgar Schulz, Catharina Schuetz, Joachim Freihorst, Ulrich Baumann, Willy A. Flegel, Klaus-Michael Debatin, Wilhelm Friedrich

Blood (2005) 106 (11): 1439.

https://doi.org/10.1182/blood.V106.11.1439.1439

Published: 2005

Journal Articles

Rhesus Box Variation: Multiple RHD Deletion Events and Implications for Testing RHD Heterozygosity.

Willy A. Flegel, MD, Joann M. Moulds, PhD, Franz F. Wagner, MD

Blood (2004) 104 (11): 2705.

https://doi.org/10.1182/blood.V104.11.2705.2705

Published: 2004

NARROW

Predictors, Risk Factors and Outcomes of Patients with SAA with Anti-HLA Class I Antibodies Treated with Immunosuppressive Therapy

HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia

COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination

Immune Hemolysis after a Hematopoietic Progenitor Cell Transplantation for Sickle Cell Disease: A Case Report

Rapid Engraftment, Immune Recovery, and Resolution of Transfusion Dependence in Treatment-Refractory Severe Aplastic Anemia Following Transplantation with Ex Vivo Expanded Umbilical Cord Blood (Omidubicel)

Spectrum and Clinical Significance of HLA Class I Alleles and Their Somatic Mutations in Immune Aplastic Anemia

Rapid Engraftment and Immune Recovery in Treatment Refractory Severe Aplastic Anemia Patients Undergoing Ex Vivo Nicotinamide-Expanded (NAM-Expanded) Unrelated Cord Blood Transplantation

Continuous Platelet Transfusion As a Potential Desensitization Regimen in HLA Class I Alloimmune-Mediated Platelet Refractoriness

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

Complement Inhibition Using Eculizumab Overcomes Platelet Transfusion Refractoriness in Allo-Immunized Patients Receiving HLA Mismatched Platelets

Excellent Engraftment and Long-Term Survival in Patients with Severe Aplastic Anemia (SAA) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Haplo-Identical CD34+ Cells Combined with a Single Umbilical Cord Blood Unit

Minor Histocompatibility Antigen Mismatch and Incidence of Graft Versus Host Disease, Event-Free, and Overall Survival in Patients Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation

SNP Genotyping and LD Testing in ERMAP : Revealing Scianna Blood Group Diversity in NIH Blood Donors

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

HLA Alloantibody Persistence and De Novo Production of HLA Alloantibodies of Donor Origin Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management

Direct Antiglobulin Test, Ferritin and GPI-Negative Cell Populations in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) during Eculizumab Therapy: Extravascular Hemolysis Unmasked by Efficient Eculizumab-Mediated Inhibition of Intravascular Hemolysis.

Successful Allogeneic HSCT in a Patient with Chronic Granulomatous Disease and McLeod Phenotype after Sensitization to Kx- and K- Antigens.

Rhesus Box Variation: Multiple RHD Deletion Events and Implications for Testing RHD Heterozygosity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only